Alexion Pharmaceuticals
Jon Vlasnik is a seasoned professional in health economics and outcomes research, currently serving as Director of US Health Economics & Outcomes Research at Alexion Pharmaceuticals, Inc. since January 2020. Previously held positions include Director of Health Outcomes at LEO Pharma and Senior Associate Director of Health Economics & Outcomes Research at Boehringer Ingelheim. Jon Vlasnik began the career as an Employer Medical Outcomes Specialist at Pfizer and has experience as a Clinical Pharmacist in CardioThoracic ICU at Barnes-Jewish Hospital. Educational qualifications include a Certificate in Health Economics and Outcomes Research from the University of Washington and a Critical Care Residency in Pharmacy from the Medical University of South Carolina.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.